🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you Gastroenterology Advisor for highlighting our recent work on MASLD/AIH patients. gastroenterologyadvisor.com/news/higher-tr… onlinelibrary.wiley.com/doi/10.1111/li… Alan Bonder Hirsh D. Trivedi, MD, MS Ana Marenco Flores

📑 Development and validation of a biomarker index for HCC treatment response❗️ ⭐️LAD Score 🟰 AFP-L3, AFP, and DCP journals.lww.com/hepcomm/fullte…

How to resmetirom Practice guidelines from AASLD led by Michigan Hepatology’s own Vincent Chen Open access: pdfs.journals.lww.com/hep/9900/resme…

Have you ever wondered which #corticosteroid to use for severe #alcohol-associated hepatitis? Prednisolone? Prednisone? Metilpred? #LiverTwitter #GITwitter Read here: 👇👇👇 at Hepatology Communications Elliot Tapper journals.lww.com/hepcomm/fullte…

HbA1c predicts regression and progression in MASLD. Diabetes - higher progression. Huge work by ⁦Daniel Huang⁩ ⁦Rohit Loomba⁩ #livertwitter ⁦AASLD⁩ #TLM24

Resistance training isn’t just for strength—it’s a powerhouse for #liver health too! 💪 SR + MA shows significant reductions in liver fat, liver enzymes, IR in #MASLD with RT (6 studies, 232 adults) 😲😲Adherence >90%! 🏋️‍♀️ #ExerciseIsMedicine pubmed.ncbi.nlm.nih.gov/39589803/

🔥 🆙 to publish this work with Hirsh D. Trivedi, MD, MS and team regarding the importance of #exercise across all types and stages of steatotic liver disease! Check it out here: onlinelibrary.wiley.com/doi/10.1111/li…

I am glad that this is on the news. We have known this for a number of years. Alcohol (even small amounts) increases the risk of liver disease, cardiovascular disease and cancer, among others. Here our recent article: pubmed.ncbi.nlm.nih.gov/37992972/ #ALDsig #ALDcure #LiverTwitter #LiverX

Don't miss Part 1 of this expert roundtable on MASLD/MASH with Alan Bonder Z. Gordon Jiang and Hirsh D. Trivedi, MD, MS hmpgloballearningnetwork.com/site/gastro/vi…

NEJM AI Starting with more than 2M echocardiogram videos, Yuki Sahashi and Dr. Alan Kwan identified cases of paired abdominal ultrasounds (diagnosing Liver Dz) and echo studies to train an AI algorithm to identify #MASLD and #cirrhosis.

NEJM AI Yuki Sahashi Smidt Heart Institute at Cedars-Sinai Milos Vukadinovic Hirsh D. Trivedi, MD, MS Jonathan H Chen MD PhD Justin Rhee #EchoNet-Liver performs well in both Stanford Medicine as well as CSMC Smidt Heart Institute at Cedars-Sinai cohorts, including comparison with abdominal MRI diagnosed liver disease.

Statin use is associated with lower risks of hepatocellular carcinoma (HCC) and hepatic decompensation, and improved fibrosis progression in patients with chronic liver disease. ja.ma/4ia1S5a

Fresh off the press! Did you know? PSC risk scores are great toolsin healthcare! 🩺✨ These tools help clinicians risk-stratify patients, enabling personalized care plans and better outcomes. 💡 #HealthcareInnovation #PatientCare #PSCRiskScores mdpi.com/2077-0383/14/6…

The liver loves aerobic exercise journals.lww.com/hepcomm/fullte… Shelley Keating

How does exercise and fitness promote healthy brain aging? An outstanding, comprehensive review The Lancet reduced neuroinflammmation, preserves blood-brain-barrier, neurogenesis, role of exerkines, and much more thelancet.com/journals/lance… Atefe R. Tari Ulrik Wisloff CERG NTNU

🧵1/10 🚨 First-ever global guidelines for managing MASLD in T2DM are here! Grateful to anoop misra for leading this effort and for including me as a co-author. This thread summarizes key takeaways that can guide physicians in managing these patients. authors.elsevier.com/c/1kwHL6fWV2v7…

In this interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly semaglutide improved liver histologic results at 72 weeks. Full ESSENCE trial results: nej.md/3EVFAFM

Challenge the guideline: 🌟Baclofen may NOT be safe for ALD compensated cirrhosis, per our multicenter cohort with lab data and longitudinal follow up 🌟Previous RCT that supported baclofen only had <40 pts using baclofen and was not powered for safety 🌟Call upon Motivational

Our machine learning prediction model for ACLF mortality got Poster of Distinction. 👍outperforms CLIF-C ACLF and MELD 3.0 👍An explainable ML model —> not blackbox ML model anymore 👍A easy-to-use website for clinicians and researchers ❌not all organ failures are equally bad

Hard to beat the mix of learning, inspiration, and community at #DDW2025. So lucky to have phenomenal mentors Hirsh D. Trivedi, MD, MS and Dr. Benham Saberi and reconnect with friends who make this journey special.. Mohammad Abudalou Jad Mitri Dimo Dimitrov, MD Ximena Parraga